Sfoglia per AUTORE
ASCIERTO PA
Collezione AO Cuneo

  

Items : 5

Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma. in Journal of translational medicine / J Transl Med. 2022 Apr 5;20(1):159. doi: 10.1186/s12967-022-03359-x.

2022
AO Cuneo

Guida M; Bartolomeo N; Quaresmini D; Quaglino P; Madonna G; Pigozzo J; Di Giacomo AM; Minisini AM; Tucci M; Spagnolo F; Occelli M; Ridolfi L; Queirolo P; De Risi I; Valente M; Sciacovelli AM; Chiarion Sileni V; Ascierto PA; Stigliano L; Strippoli S;

No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study. in Cancers / Cancers (Basel). 2021 Jan 26;13(3):475. doi: 10.3390/cancers13030475.

2021
AO Cuneo

Ascierto PA; Chiaron Sileni V; Gambale E; Quaresmini D; De Risi I; Queirolo P; Ridolfi L; Occelli M; Spagnolo F; Tucci M; Minisini AM; Di Giacomo AM; Pigozzo J; Quaglino P; Madonna G; Bartolomeo N; Guida M; Stigliano L; Strippoli S; On Behalf Of The Italian Melanoma Intergroup Imi Study;

JAK Inhibition with Ruxolitinib in Patients with COVID-19 and Severe Pneumonia: Multicenter Clinical Experience from a Compassionate Use Program in Italy. in Journal of clinical medicine / J Clin Med. 2021 Aug 23;10(16):3752. doi: 10.3390/jcm10163752.

2021
AO Cuneo
ASL Alessandria
AOU San Luigi di Orbassano

Tedeschi A; Festuccia MB; Monforte AD; Capochiani E; Selleri C; Simonetti F; Saracino A; Rapezzi D; Badagliacca MR; Falasca K; Molteni A; Palazzolo R; Schettino G; Bocchia M; Turrini M; Ascierto PA; Paley C; Saglio G; Coco P; D'Alessio A; Zuurman M; Morelli M; Mortara A; Vannucchi AM;

Real Life Clinical Management and Survival in Advanced Cutaneous Melanoma: The Italian Clinical National Melanoma Registry Experience. in Frontiers in oncology / Front Oncol. 2021 Jul 8;11:672797. doi: 10.3389/fonc.2021.672797. eCollection 2021.

2021
AOU Alessandria
AO Cuneo

Testori A; Palmieri G; Rossi CR; Gandini S; Budroni M; Celentano E; Toffolutti F; Mastrangelo G; Fabrizio T; Calvani N; Atzori L; Massa D; Gatti A; Grosso F; Cairo G; Occelli M; Guida M; De Giorgi V; Barruscotti S; Marussi D; Giordano M; Ribero S; Quaglino P; Nacchiero E; Giudice G; Tosti G; Pennacchioli E; Caracò C; Vanella V; et alii...

Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge 2018" (28-29 November, 2018, Naples, Italy). in Journal for immunotherapy of cancer / J Immunother Cancer. 2019 Nov 29;7(1):332. doi: 10.1186/s40425-019-0798-3.

2019
AO Cuneo

Ascierto PA; Bifulco C; Buonaguro L; Emens LA; Ferris RL; Fox BA; Delgoffe GM; Galon J; Gridelli C; Merlano M; Nathan P; Odunsi K; Okada H; Paulos CM; Pignata S; Schalper KA; Spranger S; Tortora G; Zarour H; Butterfield LH; Puzanov I; Ascierto PA; Bifulco C; Buonaguro L; Emens LA; Ferris RL; Fox BA; Delgoffe GM; Galon J; et alii...